# GLP-1 prescriptions for people with no medical need are climbing

> **Open Intelligence Dossier** · First detected: 2026-09-23 13:40 UTC · Category: Health

## Executive Summary
Prescriptions for GLP-1 drugs like Ozempic among Americans without medical needs are surging across multiple demographic groups.

## Intelligence Brief
Recent coverage from outlets including 매일경제, Medscape, The New York Times, and The Seattle Times details a significant upward trend in the use of glucagon-like peptide-1 medications. Specifically, reporting highlights that more than 1.1 million Americans are currently using these drugs, which include medications such as Ozempic, without a documented medical reason or condition. This phenomenon represents a growing off-label usage pattern that has been documented since 2021. Media reports emphasize that this off-label utilization is not uniform across the population.


According to the available sources, the surge in prescriptions for individuals lacking a medical necessity is unevenly distributed among different demographic groups. The coverage underscores that this trend encompasses a substantial population utilizing powerful pharmaceutical treatments outside of their intended clinical parameters. Context provided by the reporting indicates that this trend has been developing over a period of years, with off-label surges tracking upward since 2021. The widespread attention from major publications points to broader questions regarding prescription practices, medication accessibility, and the oversight of treatments originally designed for specific clinical indications.


As the situation continues to develop, future coverage will likely monitor regulatory responses, prescribing guidelines, and further demographic analyses. Specific outcomes, policy changes, and the exact clinical implications of widespread non-medical use remain to be seen as the data surrounding these prescription patterns is continually updated by researchers and health organizations.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| 매일경제 | More than 1.1 million Americans use glucagon-like peptide-1 (GLP-1) drugs such as Ozempic without co.. | [Source Link](https://news.google.com/rss/articles/CBMiS0FVX3lxTE1WQWNwOEd6RWprb0VVMUYzZ0NFRE1VTjdlOThPSUk3ZVpzaFF4Y3h1SzdLbDRfS2VpVXRwT2ZrWW9pbzNwQWZCZUNlMA?oc=5) |
| Medscape | Off-Label GLP-1 Surges Since 2021, Uneven Across Groups | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxOaXdNVG9EWnNTd0IxRHZXQ0hpWWtkSkFoMlZRRWVLc3ZaYXQtWHNiMkx5THc4Q29SVFNmaEpPREtxemk1bUt1bWE1dmZYTE56bk5VRzB2Q21BYWQ5eXRyUVVoMnV5SWstWV9rNW1kRkU3VG04WDNWbjluSk9Dd0dtSmU0R21hQWJsZDdmbnNVUnJ4MWJkUmZOQ0hB?oc=5) |
| The New York Times | Many Americans Use GLP-1 Drugs Without a Medical Reason, Study Shows | [Source Link](https://news.google.com/rss/articles/CBMifEFVX3lxTE5VcEFRcWJ3X2hTUTVReFlRTUd5VTdReEpyS25IRXdwZE9EUDVzbkZzbDhwb0xUU1hzNTdrWHFkaFB4R2x6YU9BRDk1NE1OY1F3SkpoRXVpMjJ4UUJlbHluV3ZYV2NueUJkckQyaG9tcmk0dWdlb3c4MUQ1M24?oc=5) |
| The Seattle Times | GLP-1 prescriptions for people with no medical need are climbing | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxOUFNuNENvaVZNVTF1eHF0YXcxLXM1RjA0dFVOQ0JvMmtZM1BMd2c0THBUSnpBcWwyYXJEQ2p4eHN4cVhkaTE2MHd1Q2FxZWxuMkNQa1l1VmtnUkEwQzdZa2QybUppYU5sM01IWnNzbjk1eThVYXJCQ0puTmJTQlp3czdUNk1fWWxmUEttSUw5R29BeERaU1RZM0Y1NlUwbGpWdVM4Q0ZOVTBmb0U?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-09-23/glp-1-prescriptions-for-people-with-no-medical-need-are-climbing*
